Up next

Autoplay

Managing Toxicities from Chronic Myeloid Leukemia Treatment

2 Views • 07/08/23
Share
Embed
administrator
administrator
Subscribers
0

The panelists, Jorge Cortes, MD; Javier Pinilla-Ibarz, MD, PhD; Kevin Kelly, MD, PhD; David Snyder, MD, FACP; and Harry Erba, MD, PhD, comment on strategies to manage adverse events from tyrosine kinase inhibitor therapy used in the treatment of chronic myeloid leukemia.

Show more
0 Comments sort Sort By
Facebook Comments

Up next

Autoplay